Richardson D R
Department of Medicine, University of Queensland, Royal Brisbane Hospital, Brisbane, Australia.
Eur J Biochem. 2000 Mar;267(5):1290-8. doi: 10.1046/j.1432-1327.2000.01079.x.
Melanotransferrin (MTf) is a membrane-bound transferrin (Tf) homologue with several characteristics in common with serum Tf. MTf is found at high levels in melanoma cells and previous studies have shown that MTf can bind Fe. In addition, Chinese hamster ovary cells transfected with MTf transport Fe from 59Fe-citrate at greater rates than control cells. However, the role of MTf in the Fe uptake process of human melanoma cells remains unknown. In the present study we have characterized the role of MTf in Fe uptake by SK-Mel-28 melanoma cells in order to understand its function. Initial studies examined whether modulation of intracellular Fe levels using the Fe chelator desferrioxamine (DFO) or the Fe donor ferric ammonium citrate (FAC) could change MTf mRNA levels. In contrast to transferrin receptor (TfR) mRNA that increased after exposure to DFO and decreased after incubation with FAC, there was no change in MTf mRNA levels. In addition, compared to control cells, there was no alteration of 125I-labelled anti-MTf mAb-binding in cells exposed to DFO or FAC, suggesting no change in the number of MTf sites. Further studies examined the ability of DFO and FAC to modulate Fe uptake from 59Fe-citrate which is bound by MTf. In contrast to the effect of DFO or FAC at increasing and decreasing Fe uptake from 59Fe-Tf, respectively, DFO had no influence on 59Fe-citrate uptake, whereas FAC markedly increased it. Collectively, these studies suggest that MTf is not regulated in a manner similar to the TfR in response to cellular Fe levels. MTf can be removed from the membrane by phosphatidylinositol-specific phospholipase C (PtdIns-PLC). Preincubation of melanoma cells with PtdIns-PLC reduced anti-MTf mAb binding to 3% of the control, while PtdIns-PLC only slightly reduced 59Fe uptake from 59Fe-citrate. These results suggest that MTf played only a minor role in Fe uptake from 59Fe-citrate by these cells. The expression of MTf mRNA (poly A+) was also examined in 50 human tissues and found to be markedly different to Tf mRNA or TfR mRNA. Surprisingly, MTf mRNA expression was widespread in normal tissues, and was observed at its highest levels in the salivary gland. In contrast to expectations, MTf mRNA expression was generally greater in adult than fetal tissues.
黑素转铁蛋白(MTf)是一种膜结合转铁蛋白(Tf)同源物,具有一些与血清Tf相同的特征。MTf在黑色素瘤细胞中高表达,先前的研究表明MTf可以结合铁。此外,转染了MTf的中国仓鼠卵巢细胞从柠檬酸铁(59Fe)摄取铁的速率高于对照细胞。然而,MTf在人黑色素瘤细胞铁摄取过程中的作用尚不清楚。在本研究中,我们对MTf在SK-Mel-28黑色素瘤细胞铁摄取中的作用进行了表征,以了解其功能。初步研究检测了使用铁螯合剂去铁胺(DFO)或铁供体柠檬酸铁铵(FAC)调节细胞内铁水平是否会改变MTf mRNA水平。与转铁蛋白受体(TfR)mRNA不同,TfR mRNA在暴露于DFO后增加,在与FAC孵育后减少,而MTf mRNA水平没有变化。此外,与对照细胞相比,暴露于DFO或FAC的细胞中125I标记的抗MTf单克隆抗体结合没有改变,表明MTf位点数量没有变化。进一步的研究检测了DFO和FAC调节从与MTf结合的柠檬酸铁(59Fe)摄取铁的能力。与DFO或FAC分别增加和减少从59Fe-Tf摄取铁的作用相反,DFO对柠檬酸铁(59Fe)摄取没有影响,而FAC显著增加了摄取。总体而言,这些研究表明MTf对细胞铁水平的反应方式与TfR不同。MTf可以被磷脂酰肌醇特异性磷脂酶C(PtdIns-PLC)从膜上移除。用PtdIns-PLC预孵育黑色素瘤细胞可使抗MTf单克隆抗体结合减少至对照的3%,而PtdIns-PLC仅略微降低了从柠檬酸铁(59Fe)摄取铁的量。这些结果表明MTf在这些细胞从柠檬酸铁(59Fe)摄取铁的过程中仅起次要作用。我们还检测了50种人体组织中MTf mRNA(poly A+)的表达,发现其与Tf mRNA或TfR mRNA明显不同。令人惊讶的是,MTf mRNA表达在正常组织中广泛存在,在唾液腺中表达水平最高。与预期相反,MTf mRNA在成人组织中的表达通常高于胎儿组织。